Get the Daily Brief
Latest Biotech News
Advances in Cancer Immunotherapy and Tumor Microenvironment Insights
Recent studies deepen understanding of tumor-immune system interactions and identify novel immunotherapeutic targets. Van Andel Institute researchers unveiled PTGIR as a lipid-activated immune...
Precision Medicine and Genomic Advances in Rare and Pediatric Diseases
Emerging clinical guidelines and research underscore the growing role of genomic sequencing in rare and pediatric diseases for improving diagnosis and outcomes. The American Academy of Pediatrics...
Innovations in Sustainable Material Recycling and Environmental Biotechnology
Addressing critical environmental challenges, researchers are pioneering technologies for sustainable recycling and resource recovery. Teams at Dalian Institute of Chemical Physics and Peking...
Novel Therapeutics and Drug Development in Metabolic and Autoimmune Diseases
Biotech companies advance innovative medicines targeting metabolic and autoimmune disorders. Altimmune’s phase IIb trial of the GLP-1/glucagon dual receptor agonist pemvidutide in metabolic...
Breakthroughs in Regenerative Medicine and Developmental Biology
Recent studies unlock genetic and molecular mechanisms underlying mammalian regeneration and embryonic development. Two complementary studies led by Wei Wang et al. and Weifeng Lin et al. revealed...
Advances in AI and Digital Technologies Transforming Biotech and Healthcare
Artificial intelligence and computational tools continue to reshape biotechnology. Qiagen launched a digital PCR partnership program to accelerate clinical assay development through external...
Nanostics Secures Funding to Expand Prostate Cancer Test Use
Canadian biotech Nanostics has been awarded a C$3.8 million grant from Genome Canada and Genome Alberta to accelerate adoption of its ClarityDx Prostate test, which leverages machine learning to...
Portable DNA Sequencing Tracks Drug-Resistant Microbes in Wastewater
Researchers have utilized handheld DNA sequencing technology to monitor antibiotic-resistant bacteria in slaughterhouse wastewater. This approach addresses scoping challenges in conventional...
FDA Leadership Concerns Arise Over Intervention in Drug Review
Reports indicate that FDA Commissioner Marty Makary attempted to intervene in an ongoing drug review, raising concerns about regulatory independence under new leadership. The incident, described...
LatchBio Enhances Molecular Data Curation and Delivery
LatchBio announced new advances in structured bioinformatics data curation, releasing a 30 million cell atlas spanning 150 diseases with data from 200 tissues and 27 technologies. Collaborations...
HBV Infection Synergizes with Carcinogens to Drive Liver Cancer
A Nature Communications study from Mass General Brigham reveals that chronic hepatitis B virus (HBV) infection sensitizes the liver to environmental carcinogens, promoting inflammation and...
In-line NMR Empowers Orthogonal Transformation of Mixed Plastic Waste
Researchers have introduced an innovative method using in-line nuclear magnetic resonance (NMR) to analyze and selectively transform complex plastic waste mixtures into valuable chemicals....
FDA Panel Recommends New RSV Antibody for Infants
The Advisory Committee on Immunization Practices (ACIP) voted 5-2 to endorse Merck’s RSV monoclonal antibody, Enflonsia, for infants during their first respiratory syncytial virus (RSV) season if...
Incyte Names Bill Meury as New CEO amid Strategic Transition
Incyte Corporation appointed Bill Meury as CEO following Hervé Hoppenot’s retirement after 11 years at the helm. Meury brings a track record of successful pharmaceutical leadership and dealmaking,...
Vor Biopharma Shifts Focus to Autoimmune Diseases with New Funding
Vor Biopharma has redirected its strategic focus from oncology to autoimmune disease following a significant private investment of $175 million and a $4.23 billion licensing deal for telitacicept...
Blood Test Innovation in Leukemia Risk Assessment
Researchers at the Weizmann Institute of Science have developed a novel minimally invasive blood test that detects early signs of leukemia risk by analyzing genetic alterations in hematopoietic...
AI-Powered TB Diagnostics Inspired by Beetle Chemistry
Scientists at Tulane University developed ASTRA, an innovative self-powered diagnostic device inspired by the bombardier beetle’s chemical defense mechanism, enhancing tuberculosis detection...
Clinical Progress and Funding in Neurology and Biopharma
Neuron23 advanced its clinical programs with a $96.5 million Series D funding round reflecting investor confidence in neurology therapeutics. Separately, Adaptive Biotechnologies experienced a...
Innovations in Hybrid Engineered Biological Systems
An interdisciplinary review in Nature Biotechnology classifies hybrid engineered biological systems that integrate biological components with electronics and microfluidics. These cyber-physical...
AI Models Enhance Cancer Imaging and Protein Drug Discovery
At Guangzhou Medical University, an AI model named NeoPred uses dual-phase CT and clinical data to predict lung cancer tumor response preoperatively, potentially refining treatment decisions....